技术指标
指标
数值
方向
MACD(12,26,9)
-0.001
卖出
RSI(14)
44.897
中性
STOCH(KDJ)(9,3,3)
46.285
买入
ATR(14)
0.036
高波动
CCI(14)
-71.413
中性
Williams %R
53.082
中性
TRIX(12,20)
-0.326
卖出
StochRSI(14)
100.000
买入
搜索
Canopy Growth Corp
CGC添加自选
0.909USD
+0.019+2.17%
收盘 07-30 16:00（美东）报价延迟15分钟
383.58M总市值
亏损市盈率 TTM
关键数据
0.870今开
0.910最高
2.44M成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.58%换手率
0.889昨收
0.870最低
1.45M成交额
亏损市盈率静
0.77市净率
0.00%股息率 TTM
-28.83%ROA
3.28052周最高
0.94量比
-598.12M净利润
422.07M总股本
-1.3551每股收益TTM
2.42Beta
-48.50%ROE
1.18052周最低
4.50%振幅
11.60%毛利率
383.58M总市值
-1.20回报/风险
5.22%风险率
TradingKey Canopy Growth Corp股票评分
单位: USD 更新时间: 2026-07-29操作建议
Canopy Growth Corp当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名88/155位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价1.22。中期看，股价处于下降通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Canopy Growth Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Canopy Growth Corp亮点
亮点风险
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
估值合理
公司最新PE估值-0.66，处于3年历史合理位
机构加仓
最新机构持股46.90M股，环比增加9.85%
分析师目标
根据
3
位分析师
持有
评级
1.220
目标均价
+31.99%
涨幅空间
Canopy Growth Corp新闻
即将为您带来更多新闻，敬请期待。。。
收益预测
分析师评级
根据
3
位分析师
持有
评级
1.220
目标均价
+31.99%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
160
总数
6
中位数
9
平均值
公司名称
评级分布
分析师数
Canopy Growth Corp
CGC
3
安进
AMGN
38
Biogen Inc
BIIB
38
礼来
LLY
34
艾伯维
ABBV
33
辉瑞
PFE
32
1
2
3
...
32
技术指标
移动平均线
指标
数值
方向
MA5
0.903
买入
MA10
0.914
卖出
MA20
0.938
卖出
MA50
0.979
卖出
MA100
1.023
卖出
MA200
1.117
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Canopy Growth Corp简介
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
公司代码CGC
公司Canopy Growth Corp
CEOMongeau (Luc)
网址https://www.canopygrowth.com/
公司股东
相关品种
热门品种
常见问题
Canopy Growth Corp(CGC)的当前股价是多少？
Canopy Growth Corp(CGC)的当前股价是 0.89。
Canopy Growth Corp的股票代码是什么？
Canopy Growth Corp的股票代码是CGC。
Canopy Growth Corp股票的52周最高点是多少？
Canopy Growth Corp股票的52周最高点是3.28。
Canopy Growth Corp股票的52周最低点是多少？
Canopy Growth Corp股票的52周最低点是1.18。
Canopy Growth Corp的市值是多少？
Canopy Growth Corp的市值是373.83M。
现在Canopy Growth Corp(CGC)的股票是买入、持有还是卖出？
根据分析师评级，Canopy Growth Corp(CGC)的总体评级为signal_hold，目标价格为1.22。
Canopy Growth Corp(CGC)股票的每股收益（EPS TTM）是多少
Canopy Growth Corp(CGC)股票的每股收益（EPS TTM）是-0.63。